Significance of Siglec‐15 expression in colorectal cancer: association with advanced disease stage and fewer tumor‐infiltrating lymphocytes

Siglec‐15, a novel immune suppressor, is upregulated in many human cancers. The aim of this study was to explore the expression of Siglec‐15 in colorectal cancer (CRC), and investigate whether Siglec‐15 could be a potential target for cancer immunotherapy in patients with CRC. We performed immunohis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhao, Cheng, Pu, Huang, Fei, Li, Jiyun, Wang, Bingzhi, Zou, Shuangmei, Zheng, Zhaoxu, Peng, Chunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896156/
https://www.ncbi.nlm.nih.gov/pubmed/36424637
http://dx.doi.org/10.1002/cjp2.303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896156/
https://www.ncbi.nlm.nih.gov/pubmed/36424637
http://dx.doi.org/10.1002/cjp2.303

Ejemplares similares